Home / Inspections / 1321762

FDA Inspection 1321762 — Statline (division of MTF Biologics)

Statline (division of MTF Biologics) — FEI 3003447829

The FDA completed an inspection of Statline (division of MTF Biologics) on June 4, 2026 in Edison, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 4, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Edison, NJ (United States)

Facility

Other inspections at this facility

  • 1038849 (NAI Wed Jan 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 815288 (NAI Thu Jan 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 757123 (NAI Wed Dec 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 666879 (NAI Fri Jun 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources